Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer

Transcriptional deregulation has emerged as a hallmark of several cancer types. In metastatic castration-resistant prostate cancer, a stage in which systemic androgen deprivation therapies fail to show clinical benefit, transcriptional addiction to the androgen receptor is maintained in most patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Constantin, Theodora A., Greenland, Kyle K., Varela-Carver, Anabel, Bevan, Charlotte L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187515/
https://www.ncbi.nlm.nih.gov/pubmed/35568739
http://dx.doi.org/10.1038/s41388-022-02347-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187515/
https://www.ncbi.nlm.nih.gov/pubmed/35568739
http://dx.doi.org/10.1038/s41388-022-02347-1

Ejemplares similares